Conditions/Rectal Cancer/Chapter
Total Neoadjuvant Therapy (TNT)
Total neoadjuvant therapy delivers pelvic chemoradiation and systemic chemotherapy before surgery to deepen response and address micrometastatic risk.
TNT moves both local pelvic therapy and a full (or near-full) course of systemic chemotherapy ahead of rectal surgery in selected locally advanced cases. Goals include better tumor shrinkage, higher complete-response rates, improved odds of sphincter preservation or watch-and-wait, and earlier treatment of occult distant disease. Sequence variants exist (chemoradiation first vs induction chemotherapy first); molecular features such as dMMR/MSI-H may further alter the package.
Figure labels (English)
- Chemotherapy
- Radiotherapy
- Response assessment
Who may be a candidate?
- Locally advanced mid/low rectal cancers (e.g., T3/T4 or node-positive contexts)
- Threatened circumferential resection margin on MRI
- Patients aiming for maximal response / organ-preservation discussion
- Fit enough to complete combined neoadjuvant packages
Possible advantages
- Higher chance of deep primary-tumor response
- Earlier systemic coverage of micrometastatic risk
- May improve sphincter-preservation odds in borderline distal tumors
- Creates a structured reassessment point for watch-and-wait candidacy
Limits & realistic expectations
- Not automatic for every rectal cancer (early tumors differ)
- Toxicity: diarrhoea, marrow suppression, neuropathy, pelvic skin effects
- Requires disciplined restaging with MRI, endoscopy, and exam
- Surgery remains necessary when response is incomplete
Step-by-step overview
- 1
MRI-based staging and board review
CRM, sphincter distance, nodes, and MMR/MSI results frame TNT vs alternatives.
- 2
Start the TNT package
Chemoradiation and systemic chemotherapy in the center’s chosen order.
- 3
Supportive care during therapy
Manage toxicity so doses stay on track when safe.
- 4
Restaging interval
After completion, timed MRI + endoscopy + digital rectal exam measure response.
- 5
Decision fork
Incomplete response → TME surgery. Clinical complete response → counsel about watch-and-wait vs resection.
Key points
- Two common sequence stylesTap for details
Some programmes give chemoradiation then consolidation chemotherapy; others start with induction chemotherapy then chemoradiation. Both aim to finish local + systemic therapy before surgery.
- What chemoradiation doesTap for details
Pelvic radiation with sensitising drugs shrinks tumor, can improve CRM odds, and reduces local recurrence risk when indicated.
- What systemic chemo addsTap for details
Earlier treatment of distant micrometastatic risk and fewer patients missing adjuvant therapy because of postoperative delays.
- Restaging is a pivotal visitTap for details · key note inside
MRI fibrosis patterns, endoscopic scar without mass, and a soft exam without nodularity inform the next step — including possible organ preservation.
- Toxicity honestyTap for details · key note inside
Diarrhoea, fatigue, cytopenias, and neuropathy need proactive management; holding doses can be safer than pushing blindly.
- ImportantTap for details · key note inside
Educational summary — TNT indication is multidisciplinary and MRI-driven.
Frequently asked questions
- What is TNT?Tap for details
Total neoadjuvant therapy delivers chemotherapy and radiation before surgery in selected rectal cancers.
- Is TNT automatic for every rectal tumor?Tap for details
No. Stage and location guide whether TNT is offered.
- Can TNT enable organ preservation talk?Tap for details
In selected complete responders, non-operative management may be discussed — only with disciplined follow-up.
- What if the tumor does not respond well?Tap for details
Surgery remains the backbone rescue pathway; reassessment timing is planned upfront.
More chapters in this hub
Appointment / info
Educational information only; not a substitute for clinical evaluation.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.